{"id":1006693,"date":"2026-09-29T11:23:16","date_gmt":"2026-09-29T15:23:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/"},"modified":"2026-09-29T11:23:16","modified_gmt":"2026-09-29T15:23:16","slug":"nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/","title":{"rendered":"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#8217;s Opioid Crisis"},"content":{"rendered":"<h2>\nSheridan joins independent journalist Nick Shirley to discuss how Nutriband&#8217;s AVERSA\u2122 abuse-deterrent technology is designed to help reduce the abuse, misuse, and accidental exposure driving the ongoing epidemic<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>ORLANDO, Fla., Sept.  29, 2026  (GLOBE NEWSWIRE) &#8212; Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that its CEO, Gareth Sheridan, has been featured in a new documentary by independent journalist and filmmaker Nick Shirley examining the ongoing opioid crisis in the United States. Shirley, turns his lens in this latest piece to the devastating impact of illegal opioid abuse on individuals and communities across the country \u2014 and the complex challenges surrounding some of the nation&#8217;s most commonly abused prescription medications.<\/p>\n<p>Sheridan participated in the documentary to bring a pharmaceutical innovation perspective to the conversation, discussing how technologies such as Nutriband&#8217;s AVERSA\u2122 abuse-deterrent platform are designed to help reduce the risk of abuse, misuse, diversion, and accidental exposure associated with high-risk medications \u2014 while working to preserve access for the patients who depend on them for legitimate medical need.<\/p>\n<p>\u201cThe opioid crisis isn&#8217;t an abstraction \u2014 it&#8217;s a daily reality for families across this country, on both sides of addiction and genuine pain, and it demands real solutions,\u201d said Gareth Sheridan, CEO of Nutriband. \u201cI was glad to work with Nick and speak plainly about where pharmaceutical innovation fits into that fight. AVERSA\u2122 was built specifically to address this problem: giving patients who need these medications access to them, while making them fundamentally harder to abuse, misuse, or divert for people suffering from addiction or from accidental exposure.\u201d<\/p>\n<p>The full documentary is available to view here: https:\/\/youtu.be\/zyDQOBp4nn4<\/p>\n<p>\n        <strong>About AVERSA\u2122 Abuse-Deterrent Transdermal Technology<\/strong>\n      <\/p>\n<p>Nutriband&#8217;s AVERSA\u2122 abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The AVERSA\u2122 abuse-deterrent technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to those patients who really need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia.<\/p>\n<p>\n        <strong>About Nutriband Inc.<\/strong>\n      <\/p>\n<p>We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA\u2122 abuse-deterrent technology. AVERSA\u2122 technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.<\/p>\n<p>The Company&#8217;s website is www.nutriband.com. Any material contained in or derived from the Company&#8217;s websites or any other website is not part of this press release.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>Certain statements contained in this press release, including, without limitation, statements containing the words \u201cbelieves,\u201d \u201canticipates,\u201d \u201cexpects\u201d and words of similar import, constitute \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company&#8217;s actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company&#8217;s ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company&#8217;s business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under \u201cRisk Factors\u201d and \u201cManagement&#8217;s Discussion and Analysis of Financial Condition and Results of Operations\u201d in the Company&#8217;s Form S-1, Forms 10-K&#8217;s and Forms 10-Q&#8217;s, and the Company&#8217;s other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.<\/p>\n<p>\n        <strong>Contact Information:<\/strong><br \/>\n        <br \/>Nutriband Inc.<br \/>Phone: 407-377-6695<br \/>Email: info@nutriband.com<\/p>\n<p>\n        <strong>SOURCE: Nutriband Inc.<\/strong>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OWZkZDM4Y2YtMmJjMi00MjI1LThiZDgtNjQ5NjE2ODkxZGQ0LTEzMDgzNDktMjAyNi0wOS0yOS1lbg==\/tiny\/Nutriband-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sheridan joins independent journalist Nick Shirley to discuss how Nutriband&#8217;s AVERSA\u2122 abuse-deterrent technology is designed to help reduce the abuse, misuse, and accidental exposure driving the ongoing epidemic ORLANDO, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) &#8212; Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that its CEO, Gareth Sheridan, has been featured in a new documentary by independent journalist and filmmaker Nick Shirley examining the ongoing opioid crisis in the United States. Shirley, turns his lens in this latest piece to the devastating impact of illegal opioid abuse on individuals and communities across the country \u2014 and the complex challenges surrounding some of the nation&#8217;s most commonly abused prescription medications. Sheridan participated in the documentary to bring a pharmaceutical innovation perspective to the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#8217;s Opioid Crisis&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1006693","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#039;s Opioid Crisis - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#039;s Opioid Crisis - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Sheridan joins independent journalist Nick Shirley to discuss how Nutriband&#8217;s AVERSA\u2122 abuse-deterrent technology is designed to help reduce the abuse, misuse, and accidental exposure driving the ongoing epidemic ORLANDO, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) &#8212; Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that its CEO, Gareth Sheridan, has been featured in a new documentary by independent journalist and filmmaker Nick Shirley examining the ongoing opioid crisis in the United States. Shirley, turns his lens in this latest piece to the devastating impact of illegal opioid abuse on individuals and communities across the country \u2014 and the complex challenges surrounding some of the nation&#8217;s most commonly abused prescription medications. Sheridan participated in the documentary to bring a pharmaceutical innovation perspective to the &hellip; Continue reading &quot;Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#8217;s Opioid Crisis&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-29T15:23:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#8217;s Opioid Crisis\",\"datePublished\":\"2026-09-29T15:23:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/\"},\"wordCount\":772,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/\",\"name\":\"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=\",\"datePublished\":\"2026-09-29T15:23:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#8217;s Opioid Crisis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/","og_locale":"en_US","og_type":"article","og_title":"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis - Market Newsdesk","og_description":"Sheridan joins independent journalist Nick Shirley to discuss how Nutriband&#8217;s AVERSA\u2122 abuse-deterrent technology is designed to help reduce the abuse, misuse, and accidental exposure driving the ongoing epidemic ORLANDO, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) &#8212; Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that its CEO, Gareth Sheridan, has been featured in a new documentary by independent journalist and filmmaker Nick Shirley examining the ongoing opioid crisis in the United States. Shirley, turns his lens in this latest piece to the devastating impact of illegal opioid abuse on individuals and communities across the country \u2014 and the complex challenges surrounding some of the nation&#8217;s most commonly abused prescription medications. Sheridan participated in the documentary to bring a pharmaceutical innovation perspective to the &hellip; Continue reading \"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#8217;s Opioid Crisis\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-29T15:23:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#8217;s Opioid Crisis","datePublished":"2026-09-29T15:23:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/"},"wordCount":772,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/","name":"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=","datePublished":"2026-09-29T15:23:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNTU3MiM3ODY4MzQwIzIyOTY3OTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-featured-in-new-nick-shirley-documentary-confronting-americas-opioid-crisis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America&#8217;s Opioid Crisis"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1006693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1006693"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1006693\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1006693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1006693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1006693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}